News

A gene therapy recently approved by the FDA to treat patients with Sickle Cell Anemia is now being administered in St. Louis.
Experts make case for early testing, prevention and care In this report, VINCENT KURAUN explores the groundbreaking ...
Scientists in the US have performed the first personalised gene therapy on a child with a life-threatening rare disease, ...
Editas Medicine reports successful gene editing levels in stem cells, supporting potential treatment for sickle cell disease and beta thalassemia. Editas Medicine announced promising new data ...
Health camp certifies 35 sickle cell patients for disability benefits, emphasizing prevention, early detection, and community support.
In June, the Centers for Medicare & Medicaid Services (CMS) will name the participating states for the agency’s new Cell and ...